Israel - Hebräisch - Ministry of Health

k.s.kim international ltd - dabigatran etexilate - קפסולות - dabigatran etexilate 75 mg - dabigatran etexilate

Israel - Hebräisch - Ministry of Health

novo nordisk ltd., israel - insulin degludec; liraglutide - תמיסה להזרקה - insulin degludec 100 u/ml; liraglutide 3.6 mg/ml - insulin degludec and liraglutide

Israel - Hebräisch - Ministry of Health

teva israel ltd - citalopram as hydrobromide - טבליות מצופות פילם - citalopram as hydrobromide 20 mg

Israel - Hebräisch - Ministry of Health

abic ltd. - omeprazole - קפסולות - omeprazole 20 mg - omeprazole - omeprazole - acute duodenal ulcer. acute gastric ulcer. helicobacter pylori-associated peptic ulcer disease in combination with antibiotics. reflux esophagitis:- treatment ; - long-term management; - maintenance treatment for the prevention of relapse in patients with severe reflux esophagitis. treatment of severe reflux oesophagitis in children from one year of age and older. - maintenance treatment for the prevention of relapse in patients with poorly responsive peptic ulcer. - zollinger-ellison syndrome. - treatment and prevention of nsaid - associated duodenal and gastric ulcers or erosions in high risk patients.

Israel - Hebräisch - Ministry of Health

abic ltd. - omeprazole - קפסולות - omeprazole 20 mg - omeprazole - omeprazole - relief of reflux-like symptoms (e.g. heartburn) with frequency of two or more days a week in sufferers aged 18 and over.

Israel - Hebräisch - Ministry of Health

teva israel ltd - clopidogrel as bisulfate - טבליה - clopidogrel as bisulfate 75 mg - clopidogrel - clopidogrel - clopidogrel is indicated for the prevention of atherothrombotic events as follows : * recent mi recent stroke or established peripheral arterial disease : - patients suffering from myocardial infarction (from a few days until less than 35 days ) - ischaemic stroke ( from 7 days until less than 6 months) or established peripheral arterial disease. - for patients with a history of recent myocardial infarction (mi) recent stroke or established peripheral arterial disease - clopidogrel has been shown to reduce the rate of a combined endpoint of new ischemic stroke (fatal or not) new mi (fatal or not) and other vascular death. * acute coronary syndrome: - for patients with acute coronary syndrome [non-st segment elevation acute coronary syndrome (unstable angina/non-q-wave mi) or st segment elevation acute myocardial infarction ] in combination with asa in medically treated patients eligible for thrombolytic therapy and those who are to be managed with percutaneous coronary intervention (with or without stent) or

Israel - Hebräisch - Ministry of Health

teva israel ltd - risperidone - אבקה וממס להכנת תרחיף בשחרור ממושך להזרקה - risperidone 25 mg/vial - risperidone

Israel - Hebräisch - Ministry of Health

teva israel ltd - risperidone - אבקה וממס להכנת תרחיף בשחרור ממושך להזרקה - risperidone 37.5 mg/vial - risperidone

Israel - Hebräisch - Ministry of Health

teva israel ltd - risperidone - אבקה וממס להכנת תרחיף בשחרור ממושך להזרקה - risperidone 50 mg/vial - risperidone

Israel - Hebräisch - Ministry of Health

sanofi israel ltd - alfuzosin hydrochloride - טבליות עם שחרור מושהה - alfuzosin hydrochloride 5 mg - alfuzosin - alfuzosin - treatment of certain functional symptoms of benign prostatic hypertrophy, particularly if surgery has to be delayed for some reason